Craig Venter will be awarded the Dickson Prize in Medicine from the University of Pittsburgh for his contributions in sequencing and mapping the first draft of the human genome.
Venter is the founder and president of the J. Craig Venter Institute and founder and CEO of Synthetic Genomics. He holds a BS as well as a PhD in pharmacology and physiology from the University of California, San Diego.